182 related articles for article (PubMed ID: 1350797)
1. Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives.
Ohshima E; Otaki S; Sato H; Kumazawa T; Obase H; Ishii A; Ishii H; Ohmori K; Hirayama N
J Med Chem; 1992 May; 35(11):2074-84. PubMed ID: 1350797
[TBL] [Abstract][Full Text] [Related]
2. A new series of antiallergic agents. I. Synthesis and activity of 11-(2-aminoethyl)thio-6,11-dihydrodibenz[b,e]oxepin derivatives.
Ohshima E; Kumazawa T; Takizawa H; Harakawa H; Sato H; Obase H; Oiji Y; Ishii A; Ishii H; Ohmori K
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2724-8. PubMed ID: 1687210
[TBL] [Abstract][Full Text] [Related]
3. A new series of antiallergic agents. II. Synthesis and activity of new 6,11-dihydrodibenz[b,e]oxepin-carboxylic acid derivatives.
Kumazawa T; Ohshima E; Harakawa H; Sato H; Obase H; Oiji Y; Ishii A; Ishii H; Ohmori K
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2729-33. PubMed ID: 1687211
[TBL] [Abstract][Full Text] [Related]
4. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
Ohmori K; Hayashi K; Kaise T; Ohshima E; Kobayashi S; Yamazaki T; Mukouyama A
Jpn J Pharmacol; 2002 Apr; 88(4):379-97. PubMed ID: 12046981
[TBL] [Abstract][Full Text] [Related]
6. Dibenz[b,e]oxepin derivatives: novel antiallergic agents possessing thromboxane A2 and histamine H1 dual antagonizing activity. 1.
Ohshima E; Takami H; Harakawa H; Sato H; Obase H; Miki I; Ishii A; Ishii H; Sasaki Y; Ohmori K
J Med Chem; 1993 Feb; 36(3):417-20. PubMed ID: 8093908
[No Abstract] [Full Text] [Related]
7. Synthesis of a dibenz[b,e]oxepin-bovine serum albumin conjugate for radioimmunoassay of KW-4679 ((Z)-11-[3-(dimethylamino)propylidene]-6,11- dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride).
Ohshima E; Sato H; Obase H; Uchimura T; Kuwabara T; Kobayashi S
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2552-4. PubMed ID: 1446376
[TBL] [Abstract][Full Text] [Related]
8. Study on zwitter-ionization of drugs. II. Synthesis and pharmacological activity of some N-[3-(5H-dibenzo[a, d]cyclohepten-5-ylidene) propyl]-N-methylamino- and N-[3-(6H-dibenz[b, e]oxepin-11-ylidene) propyl]-N-methylamino-alkanoic acid derivatives and related compounds.
Muramatsu H; Sawanishi H; Iwasaki N; Kakiuchi M; Ohashi T; Kato H; Ito Y
Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):1987-93. PubMed ID: 8293521
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
[TBL] [Abstract][Full Text] [Related]
10. Unique binding pocket for KW-4679 in the histamine H1 receptor.
Nonaka H; Otaki S; Ohshima E; Kono M; Kase H; Ohta K; Fukui H; Ichimura M
Eur J Pharmacol; 1998 Mar; 345(1):111-7. PubMed ID: 9593602
[TBL] [Abstract][Full Text] [Related]
11. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological studies on KW-4679, an antiallergic drug. (1): Inhibitory effect on passive cutaneous anaphylaxis (PCA) and experimental asthma in rats and guinea pigs].
Ishii H; Sasaki Y; Ikemura T; Kitamura S; Ohmori K
Nihon Yakurigaku Zasshi; 1995 Oct; 106(4):289-98. PubMed ID: 8537076
[TBL] [Abstract][Full Text] [Related]
13. Effect of (Z)-11-[3-(dimethylamino) propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride on experimental allergic conjunctivitis and rhinitis in rats and guinea pigs.
Kamei C; Sugimoto Y; Nakamura S; Zhong C
Arzneimittelforschung; 1995 Sep; 45(9):1005-8. PubMed ID: 7488300
[TBL] [Abstract][Full Text] [Related]
14. Effect of terfenadine and KW-4679, a novel antiallergic compound, on action potential of guinea pig ventricular myocytes.
Kato Y; Mori T; Ohmori K; Ichimura M
Jpn J Pharmacol; 1996 Feb; 70(2):199-202. PubMed ID: 8866759
[TBL] [Abstract][Full Text] [Related]
15. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
[TBL] [Abstract][Full Text] [Related]
16. Preclinical comparison of ebastine and other second generation H1-antihistamines.
Yakuo I; Yabuuchi M; Ito T
Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966
[TBL] [Abstract][Full Text] [Related]
17. Dibenzoxepin derivatives: thromboxane A2 synthase inhibition and thromboxane A2 receptor antagonism combined in one molecule.
Ohshima E; Sato H; Obase H; Miki I; Ishii A; Kawakage M; Shirakura S; Karasawa A; Kubo K
J Med Chem; 1993 May; 36(11):1613-8. PubMed ID: 8496929
[TBL] [Abstract][Full Text] [Related]
18. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K
Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
[TBL] [Abstract][Full Text] [Related]
19. Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 2.
Ohshima E; Takami H; Sato H; Mohri S; Obase H; Miki I; Ishii A; Shirakura S; Karasawa A; Kubo K
J Med Chem; 1992 Sep; 35(18):3402-13. PubMed ID: 1388208
[TBL] [Abstract][Full Text] [Related]
20. Amphoteric drugs. I. Synthesis and antiallergic activity of [4-(diphenylmethoxy)piperidino]-, [4-(diphenylmethyl)piperazinyl]- and [4-(diphenylmethylene)piperidino]alkanoic acid derivatives.
Iwasaki N; Sakaguchi J; Ohashi T; Takahara E; Ogawa N; Yasuda S; Koshinaka E; Kato H; Ito Y; Sawanishi H
Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2276-84. PubMed ID: 7859328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
